In the current higher-for-longer interest rate regime, more fixed income investors are seeking alternate paths to diversify their income sources. One option that may not have yet considered is private credit or more specifically, the Simplify Private Credit Strategy ETF (PCR) .
PCR offers a compelling alternative or complement to traditional corporate bonds by providing institutional-grade private credit exposure within an ETF wrapper. Of course, there’s also its distribution rate of 11.48% (as of May 31, 2026), which will appease income seekers.
Key Takeaways:
- PCR offers institutional-grade exposure within a liquid ETF wrapper, sporting an 11.48% distribution rate for income-focused investors.
- The fund primarily invests in business development companies and closed-end funds that hold floating-rate senior secured loans, allowing its coupon payouts to adjust alongside benchmark rates like SOFR.
- By utilizing total return swaps to replicate the VettaFi Private Credit Index, PCR bypasses the heavy duration risk of corporate bonds while capturing a significant yield premium in high-interest rate environments.
See More: Private Credit Sees Rise in Acceptance For DC Plan Portfolios
Benefits of Private Credit
Tightening spreads make corporate bonds an enticing option, but private credit has inherent benefits that also make it worth a closer look. Corporate bonds are highly sensitive to duration and interest rate volatility so they can be subjected to the actions of the U.S. Federal Reserve’s monetary policy. Alternatively, the underlying holdings in PCR are primarily Business Development Companies (BDCs) and closed-end funds, which utilize floating-rate senior secured loans that can adapt to the Fed’s interest rate policy.
As a result of this BDC and closed-end fund exposure, these coupons reset alongside benchmarks like the Secured Overnight Financing Rate (SOFR). That said, the fund an mitigate interest rate sensitivity and capture wider spreads, making it particularly resilient in “higher-for-longer” rate environments.
Furthermore, PCR offers a significant yield premium over standard corporate bond benchmarks, providing an attractive path for income-focused investors to preserve purchasing power against persistent inflation.
Systematically Active Flexibility
The goal of PCR is to generate income and capital appreciation by investing the majority of its net assets in securities found within the VettaFi Private Credit Index. To achieve its investment objective, PCR invests in total return swaps linked to the index’s constituents. The index specifically tracks private credit instruments held by publicly traded U.S. business development companies and closed-end funds that allocate over 50% of their portfolios to non-publicly traded corporate loans, syndicated debt, or high-yield bonds.
PCR gives investors exposure to private credit with the accessibility, liquidity, and cost efficiency of an ETF wrapper.
For more news, information, and strategy, visit the Institutional Income Strategies Content Hub.
VettaFi LLC (“VettaFi”) is the index provider for PCR, for which it receives an index licensing fee. However, PCR is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of PCR.
